|
Larina V.N., Lunev V.I.
Phenotypic clusters of patients with heart failure and ejection fraction 40% or more: A comparative observational study
|
№9 / 2024
|
|
Davydova N.A., Lebedev P.A., Chernyshev A.V., Kornilin D.V., Grishanov V.N., Komarova M.V.
Clinical and prognostic value of the skin autofluorescence parameter in coronary heart disease and peripheral arterial disease patients
|
№2 / 2024
|
|
Karoli N.A., Borodkin A.V., Rebrov A.P.
Risk factors for the development of adverse outcomes in patients with chronic obstructive pulmonary disease
|
№5 / 2022
|
|
Larina V.N., Larin V.G.
The place of bisoprolol cardioselective beta-adrenoblocker in treatment of patients with different chronic heart failure phenotypes
|
№1 / 2022
|
|
Resolution of the Council of experts on scientific experience exchange of antiplatelet drugs use, including acetylsalicylic acid for prevention of COVID-19 arterial vascular complications in different time periods of the disease
|
№9 / 2021
|
|
Ignatova I.V., Blinova E.V., Antonov V.N.
Analysis of factors of poor outcome in patients with COPD and type 2 diabetes mellitus: results of a 10-year follow-up
|
№8 / 2021
|
|
Avdeev S.N.
Modern approaches to acute exacerbation of idiopathic pulmonary fibrosis
|
№6 / 2019
|
|
Tkachev A.V., Mkrtchyan L.S., Mazovka K.E.
Ulcerative colitis: validity of disease activity indexes and prediction of therapy effect
|
№3 / 2019
|
|
K.S. Fazulina, V.V. Fomin, V.V. Meshalkina
Disturbances of water and electrolyte homeostasis as a predictor of an unfavorable long-term prognosis in patients hospitalized for decompensated CHF
|
№3 / 2018
|
|
L.P. Ananyeva, O.A. Koneva, L.V. Teplova, V.N. Lesnyak
Features of interstitial lung damage in systemic scleroderma (literature review and authors’ own data)
|
№4 / 2017
|
|
A.I. Martynov, Ye.V. Akatova, O.P. Nikolin, I.V. Urlayeva
Type A behavior as a risk factor of acute coronary syndrom
|
№1 / 2016
|
Русский
